Regeneron Pharmaceuticals
Regeneron is a leading commercial-stage biotechnology company transforming science to medicine for patients with serious diseases. We are advancing a robust oncology pipeline of novel classes and combinations in several hematologic and solid tumor types, harnessing our proprietary VelociSuite® antibody production technologies. With a number of diverse candidates in early to late-phase clinical trials, Regeneron is committed to discovering, developing, and delivering innovative therapies to improve the lives of patients with cancer. Visit www.regeneroncongress.com/asco2022 for more information!